Recently, circulating fibroblast activation protein α (FAPα) shows good specificity for colorectal cancer (CRC) diagnosis, and the combination of FAPα and other multiple markers all show high sensitivity for early detection of CRC [4–5]. This evidence concerns the gene FAP and colorectal carcinoma.